Oncolytic viruses, once considered medical curiosities, are now cutting-edge tools in the fight against some of the most ...
The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...
Asian News International on MSN3d
Bharat Biotech launches India's only integrated cell, gene therapy, and viral production facilityBharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
News-Medical.Net on MSN14d
Vanderbilt researchers aim to use AI to develop antibody therapies for any targetAn ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence technologies to generate antibody therapies against any antigen target of interest.
New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...
Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback